Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21776181 | 0.88 | SMN1; SMN2 (0.41) | SMN1; SMN2MAPTNPC1RAB9AGFER | |
| SCHEMBL21883464 | 0.83 | MAPT (0.39) | SMN1; SMN2MAPTNPC1RAB9AKMT2A | |
| SCHEMBL19119672 | 0.82 | PIM1 (0.36) | SMN1; SMN2MAPTKMT2AKDM4EMAPK1 | |
| SCHEMBL20028573 | 0.82 | KDM4E (0.30) | SMN1; SMN2MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL22298393 | 0.78 | SMN1; SMN2 (0.46) | SMN1; SMN2MAPTNPC1RAB9AGFER | |
| SCHEMBL17192976 | 0.78 | L3MBTL1 (0.37) | SMN1; SMN2MAPTNPC1RAB9AKMT2A | |
| SCHEMBL24086789 | 0.76 | ELANE (0.33) | KMT2AMEN1 | |
| SCHEMBL21517327 | 0.74 | PLA2G2A (0.33) | SMN1; SMN2MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL26840950 | 0.74 | MAOB (0.36) | MAPTALDH1A1HPGDGAAALPG | |
| SCHEMBL23934862 | 0.74 | NPC1 (0.39) | SMN1; SMN2MAPTNPC1RAB9AGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3174121-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2021-11-17 | — | — | EP | disclosed |
| US-10205103-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10205103-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNE2, CRY2 | SMN1; SMN2 4537/4885MAPT 1109/4885NPC1 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.